Published in J Allergy Clin Immunol on July 01, 1991
Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. J Clin Invest (2002) 1.43
Significance of the blood beryllium lymphocyte proliferation test. Environ Health Perspect (1996) 1.20
CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells. J Clin Invest (2003) 1.19
Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response. J Clin Invest (2005) 1.17
Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med (1997) 1.16
The natural history of beryllium sensitization and chronic beryllium disease. Environ Health Perspect (1996) 1.12
Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease. J Immunol (2008) 0.97
Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects. Am J Respir Crit Care Med (2010) 0.95
Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease. J Exp Med (2013) 0.95
A reconsideration of acute Beryllium disease. Environ Health Perspect (2009) 0.92
Mutagenesis of beryllium-specific TCRs suggests an unusual binding topology for antigen recognition. J Immunol (2011) 0.92
CD27 expression on CD4+ T cells differentiates effector from regulatory T cell subsets in the lung. J Immunol (2009) 0.91
Chronic beryllium disease: an updated model interaction between innate and acquired immunity. Biometals (2010) 0.88
Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression. J Allergy Clin Immunol (2011) 0.87
Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease. Am J Ind Med (2009) 0.86
Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. Am J Respir Crit Care Med (2011) 0.86
Biological exposure metrics of beryllium-exposed dental technicians. Arch Environ Occup Health (2014) 0.86
Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease. Am J Respir Crit Care Med (2008) 0.84
Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation. J Immunol (2013) 0.83
4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease. J Immunol (2008) 0.82
Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease. Am J Respir Cell Mol Biol (2006) 0.81
Chronic beryllium disease: uncommon disease, less common diagnosis. Environ Health Perspect (1998) 0.79
Beryllium's public relations problem: protecting workers when there is no safe exposure level. Public Health Rep (2008) 0.78
CC chemokine receptor 5 gene polymorphisms in beryllium disease. Eur Respir J (2010) 0.78
Genetic variability in susceptibility to occupational respiratory sensitization. J Allergy (Cairo) (2011) 0.78
A novel alternative to environmental monitoring to detect workers at risk for beryllium exposure-related health effects. J Occup Environ Hyg (2014) 0.78
Interpreting borderline BeLPT results. Am J Ind Med (2010) 0.77
Identification of metal sensitization in sarcoid-like metal-exposed patients by the MELISA® lymphocyte proliferation test - a pilot study. J Occup Med Toxicol (2016) 0.75
Cross-Sectional Study of Respiratory Symptoms, Spirometry, and Immunologic Sensitivity in Epoxy Resin Workers. Clin Transl Sci (2015) 0.75
Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production. Am J Respir Cell Mol Biol (2009) 0.75
Current treatment of chronic beryllium disease. J Occup Environ Hyg (2009) 0.75
Acute lung affection in an endurance-trained man under amiodarone medication. Ger Med Sci (2005) 0.75
Immunotoxicology of beryllium lung disease. Environ Health Prev Med (2007) 0.75
Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada. Lung (2011) 0.75
Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol (1992) 11.24
Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27
Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA (2000) 4.36
Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol (1992) 3.79
Recent findings on preventable hospitalizations. Health Aff (Millwood) (1996) 3.66
Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. N Engl J Med (1981) 3.46
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A (1994) 3.24
Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am Rev Respir Dis (1989) 3.08
Killing of Listeria monocytogenes by inflammatory neutrophils and mononuclear phagocytes from immune and nonimmune mice. J Leukoc Biol (1984) 3.02
An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J Bone Joint Surg Am (2005) 2.92
A review of human salmonellosis: I. Infective dose. Rev Infect Dis (1983) 2.91
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 2.89
Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods (1994) 2.85
Correlation between inclination of the acetabular component and metal ion levels in metal-on-metal hip resurfacing replacement. J Bone Joint Surg Br (2008) 2.79
A novel adaptor-related protein complex. J Cell Biol (1996) 2.69
Postinjury multiple organ failure: a bimodal phenomenon. J Trauma (1996) 2.69
Revision of metal-on-metal resurfacing arthroplasty of the hip: the influence of malpositioning of the components. J Bone Joint Surg Br (2008) 2.28
Early predictors of postinjury multiple organ failure. Arch Surg (1994) 2.21
Association of blood pressure and polychlorinated biphenyl levels. JAMA (1981) 2.07
Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis (1993) 2.00
Listeria cell wall fraction: a B cell mitogen. J Immunol (1975) 1.94
Gentamicin kills intracellular Listeria monocytogenes. Infect Immun (1994) 1.94
Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol (1989) 1.86
Macrophages as accessory cells for class I MHC-restricted immune responses. J Immunol (1991) 1.85
Metal ion measurement as a diagnostic tool to identify problems with metal-on-metal hip resurfacing. J Bone Joint Surg Am (2008) 1.85
Macrophage phagocytosis: use of fluorescence microscopy to distinguish between extracellular and intracellular bacteria. J Immunol Methods (1991) 1.83
Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J Occup Med (1993) 1.81
Anatomic relationship between the pubic symphysis and ischial spines and its clinical significance in the assessment of fetal head engagement and station during labor. Ultrasound Obstet Gynecol (2009) 1.80
Building-related respiratory symptoms can be predicted with semi-quantitative indices of exposure to dampness and mold. Indoor Air (2004) 1.79
Bronchiolitis obliterans syndrome in popcorn production plant workers. Eur Respir J (2004) 1.75
Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J Biomed Mater Res (1998) 1.75
Inorganic dust pneumonias: the metal-related parenchymal disorders. Environ Health Perspect (2000) 1.72
Listeria monocytogenes infects human endothelial cells by two distinct mechanisms. Infect Immun (1995) 1.68
Cross-sectional study of a community with exceptional exposure to DDT. JAMA (1981) 1.68
Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med (2001) 1.68
Quantitative computed tomography detects air trapping due to asthma. Chest (1994) 1.67
Tissue reaction to metal on metal total hip prostheses. Clin Orthop Relat Res (1996) 1.66
Multiple organ failure can be predicted as early as 12 hours after injury. J Trauma (1998) 1.66
Enhanced accumulation of inflammatory neutrophils and macrophages mediated by transfer of T cells from mice immunized with Listeria monocytogenes. J Immunol (1985) 1.64
ATM binds to beta-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci U S A (1998) 1.63
Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J (2002) 1.63
Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3. Am J Ind Med (1996) 1.62
Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc Natl Acad Sci U S A (2000) 1.57
Roles of complement and complement receptor type 3 in phagocytosis of Listeria monocytogenes by inflammatory mouse peritoneal macrophages. Infect Immun (1991) 1.55
Reduced risk of IDDM among breast-fed children. The Colorado IDDM Registry. Diabetes (1988) 1.55
Screening blood test identifies subclinical beryllium disease. J Occup Med (1989) 1.55
Hard-rock mining exposures affect smokers and nonsmokers differently. Results of a community prevalence study. Am Rev Respir Dis (1989) 1.52
Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol (1994) 1.52
Massive femoral osteolysis and early disintegration of a polyethylene-bearing surface of a total knee replacement. A case report. J Bone Joint Surg Am (1992) 1.48
Induction of Resistance by Listeria monocytogenes Cell Wall Fraction. Infect Immun (1974) 1.48
Early risk factors for postinjury multiple organ failure. World J Surg (1996) 1.46
Uncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology (1993) 1.46
Listericidal and nonlistericidal mouse macrophages differ in complement receptor type 3-mediated phagocytosis of L. monocytogenes and in preventing escape of the bacteria into the cytoplasm. J Leukoc Biol (1992) 1.42
Contractor safety practices and injury rates in construction of the Denver International Airport. Am J Ind Med (1999) 1.41
Analysis of construction injury burden by type of work. Am J Ind Med (2000) 1.40
Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health (2001) 1.40
Requirement for bone marrow-derived cells in resistance to Listeria. J Immunol (1974) 1.40
The questionable value of medical screening in the small-group health insurance market. Health Aff (Millwood) (1995) 1.39
Endemic work-related febrile respiratory illness among construction workers. Am J Ind Med (1995) 1.39
Chemotaxigenesis and complement fixation by Listeria monocytogenes cell wall fractions. J Immunol (1977) 1.36
Notching of the femoral neck during resurfacing arthroplasty of the hip: a vascular study. J Bone Joint Surg Br (2006) 1.36
Genetically determined resistance to listeriosis is associated with increased accumulation of inflammatory neutrophils and macrophages which have enhanced listericidal activity. Immunology (1985) 1.35
Removal of immunoglobulin-bearing lymphocytes by anti-immunoglobulin-coated columns. Cell Immunol (1972) 1.32
Immunocompetent cells in resistance to bacterial infections. Bacteriol Rev (1976) 1.31
Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. J Immunol (1999) 1.31
Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr (1981) 1.30
A new method to assess fetal head descent in labor with transperineal ultrasound. Ultrasound Obstet Gynecol (2009) 1.29
Identification of pathogenic T cells in patients with beryllium-induced lung disease. J Immunol (1999) 1.29
Killing of Listeria monocytogenes by human neutrophils and monocytes, but not by monocyte-derived macrophages. J Reticuloendothel Soc (1983) 1.28
Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity. J Exp Med (1991) 1.27
Diesel asthma. Reactive airways disease following overexposure to locomotive exhaust. J Occup Med (1993) 1.27
The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int (1989) 1.24
Fungal and endotoxin measurements in dust associated with respiratory symptoms in a water-damaged office building. Indoor Air (2006) 1.23
Serial PBB levels, PCB levels, and clinical chemistries in Michigan's PBB cohort. Arch Environ Health (1982) 1.23
Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med (1997) 1.22
Studies on populations exposed to polychlorinated biphenyls. Environ Health Perspect (1985) 1.22
Construction injury rates may exceed national estimates: evidence from the construction of Denver International Airport. Am J Ind Med (1998) 1.20
Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease. Am J Respir Cell Mol Biol (1998) 1.20
Mixing and matching causing taper wear: corrosion associated with pseudotumour formation. J Bone Joint Surg Br (2012) 1.19
Sarcoidosis: immunology, rheumatic involvement, and therapeutics. Curr Opin Rheumatol (2001) 1.16
Structured research training in residency training programs. The impact on the level of resident research activity. Am J Phys Med Rehabil (1994) 1.16
Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1998) 1.16
Listeria cell wall fraction: a B cell adjuvant. J Immunol (1976) 1.16
Reduction of the potential for thermal damage during hip resurfacing. J Bone Joint Surg Br (2007) 1.15
Complement receptor type 3 (CD11b/CD18) involvement is essential for killing of Listeria monocytogenes by mouse macrophages. J Immunol (1993) 1.14
Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Am J Respir Crit Care Med (1997) 1.14
Beryllium induces IL-2 and IFN-gamma in berylliosis. J Immunol (1997) 1.14
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. Clin Cancer Res (1996) 1.14
Occupational exposure risks in individuals with PI*Z alpha(1)-antitrypsin deficiency. Am J Respir Crit Care Med (2000) 1.13
Sarcoidosis, asthma, and asthma-like symptoms among occupants of a historically water-damaged office building. Indoor Air (2009) 1.12
Thioglycolate medium decreases resistance to bacterial infection in mice. Infect Immun (1980) 1.11
Chronic beryllium disease--from the workplace to cellular immunology, molecular immunogenetics, and back. Clin Immunol Immunopathol (1994) 1.11
Genetic and environmental modulation of chronic obstructive pulmonary disease. Respir Physiol (2001) 1.10
Early pulmonary physiologic abnormalities in beryllium disease. Am Rev Respir Dis (1993) 1.09
Histocompatibility antigens in a population based silicosis series. Br J Ind Med (1989) 1.09
Clonal expansion of lung V delta 1+ T cells in pulmonary sarcoidosis. J Clin Invest (1993) 1.09